Proscia Expands AI Capabilities to Support Skin Pathology Evaluation
New skin tissue analysis tools aim to address diagnostic challenges in one of pathology's most diverse specialties.
New skin tissue analysis tools aim to address diagnostic challenges in one of pathology's most diverse specialties.
The laboratory-developed test is used to detect and monitor metastatic central nervous system cancer.
Phase 3 STAMPEDE trial data demonstrates Decipher Prostate test can predict docetaxel treatment benefit, potentially helping patients avoid unnecessary toxicity.
Two studies will evaluate circulating tumor DNA as a guide for post-surgical cancer treatment decisions.
Read MoreTwo new American Cancer Society studies reveal significant increases in colorectal cancer...
Read MoreDana-Farber Cancer Institute, Boston Children’s Hospital, and Broad Clinical Labs form BrightSeq collaborative to develop novel clinical diagnostic assays for rare pediatric cancers.
Read MoreThis marks the first time a US Food and Drug Adminstration-authorized self-collection device is available for at-home cervical cancer screening in the US.
Read MoreCoverage marks a step in expanding access to ultra-sensitive molecular residual disease detection for breast cancer patients.
Read MoreA case study shows how the noninvasive test detected Stage 1A mucinous adenocarcinoma in a high-risk patient whose previous tests and follow-up scans had suggested a low probability of cancer.
Read MoreA survey indicates a decline in cancer screening rates, contrasted by growing interest in at-home and multi-cancer early detection tests.
Read MoreResearchers have developed an LIMA1-alpha assay that can identify head and neck cancer patients who can be cured with surgery alone.
Read MoreResearchers have discovered how cellular stress and inflammation drive pancreatic cancer progression via the STAT3-ITGB3 pathway.
Read MoreResearchers have shown that molecules in exhaled breath can help detect blood cancer, paving the way for a lnon-invasive breathalyzer test.
Read MoreA new survey reveals declining cancer screening rates among U.S. adults, but shows strong interest in innovative screening methods.
Read MoreA new study introduces a dynamic biomarker system to improve early risk detection in differentiated thyroid carcinoma (DTC).
Read MoreAn highlights the growing role of microRNAs in soft tissue sarcoma (STS) research, emphasizing their promise as diagnostic biomarkers.
Read MoreNew multidisciplinary guidelines bronchoscopic lung biopsy techniques offer tissue sampling adequacy comparable to other testing methods.
Read MoreVieCure has partnered with Guardant Health to integrate Guardant’s precision oncology tests into the AI-powered Halo Intelligence platform.
Read More